Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017

Reitmajer, Markus; Leiter, Ulrike; Nanz, Lena; Amaral, Teresa; Flatz, Lukas; Garbe, Claus; Forschner, Andrea

dc.contributor.author	Reitmajer, Markus
dc.contributor.author	Nanz, Lena
dc.contributor.author	Amaral, Teresa
dc.contributor.author	Flatz, Lukas
dc.contributor.author	Garbe, Claus
dc.contributor.author	Leiter-Stöppke, Ulrike
dc.contributor.author	Forschner, Andrea Lydia
dc.date.accessioned	2025-04-01T06:22:17Z
dc.date.available	2025-04-01T06:22:17Z
dc.date.issued	2024
dc.identifier.issn	0171-5216
dc.identifier.uri	http://hdl.handle.net/10900/163514
dc.language.iso	en	de_DE
dc.publisher	New York : Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s00432-023-05533-0	de_DE
dc.subject.ddc	610	de_DE
dc.title	Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017	de_DE
dc.type	Article	de_DE
utue.quellen.id	20241001000000_03414
utue.personen.roh	Reitmajer, Markus
utue.personen.roh	Leiter, Ulrike
utue.personen.roh	Nanz, Lena
utue.personen.roh	Amaral, Teresa
utue.personen.roh	Flatz, Lukas
utue.personen.roh	Garbe, Claus
utue.personen.roh	Forschner, Andrea
dcterms.isPartOf.ZSTitelID	Journal of Cancer Research and Clinical Oncology	de_DE
dcterms.isPartOf.ZS-Issue	Article 15	de_DE
dcterms.isPartOf.ZS-Volume	150 (1)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE